Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents

Systemic inflammation represents a shared pathophysiological mechanism which underlies the frequent clinical associations among chronic inflammatory rheumatic diseases (CIRDs), insulin resistance, type 2 diabetes (T2D), and chronic diabetes complications, including cardiovascular disease. Therefore,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Marco Infante, Nathalia Padilla, Rodolfo Alejandro, Massimiliano Caprio, David Della-Morte, Andrea Fabbri, Camillo Ricordi
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: MDPI AG 2022-04-01
Σειρά:Medicina
Θέματα:
beta cell
cardiovascular disease
chronic inflammatory rheumatic diseases
diabetes
disease-modifying antirheumatic drugs
DMARDs
Διαθέσιμο Online:https://www.mdpi.com/1648-9144/58/5/571

Διαδίκτυο

https://www.mdpi.com/1648-9144/58/5/571

Παρόμοια τεκμήρια